Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07552311 · ClinicalTrials.gov registry record · NA
Generative AI Plan for Care Lab Study
A NA study, sponsored by Fitbit.
- Recruiting
- Registry status
- NA
- Development phase
- 40,000
- Enrollment target
NCT07552311: Recruiting NA study, sponsored by Fitbit.
NCT07552311 is a NA study that is actively recruiting participants, run by Fitbit. The registered enrollment target is 40,000 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (2751% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07552311, a NA study, is actively recruiting participants, sponsored by Fitbit.
- RECRUITING
- Registry status
- NA
- Development phase
- 40,000 participants
- Enrollment target
Study Summary
This is an experimental study to observe participants' interactions with the Pre-visit Lab, and the output of various generative AI models that support consumer symptom queries and provide the user with information about possible urgency, potential causes or diagnoses based on the symptoms they disclose, and a summary of information to bring to a health care visit if planned.
Primary Outcome
Determine participants' self-reported assessment of the pre-visit experience, such as satisfaction on a likert scale
Interventions
- OTHER Fitbit Plan for Care Lab
- OTHER Baseline Model
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40,000 participants |
| Start Date | 2025-11-21 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT07552311 shows while recruiting
NCT07552311 is an interventional study that assigns participants to a tested intervention. Its 40,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (2751% higher).
The record links to 0 conditions, and to 2 interventions - of which Fitbit Plan for Care Lab is the first listed.
NCT07552311 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07552311 about?
NCT07552311 is a clinical study titled "Generative AI Plan for Care Lab Study". This is an experimental study to observe participants' interactions with the Pre-visit Lab, and the output of various generative AI models that support consumer symptom queries and provide the user with information about possible urgency, potential causes or diagnoses based on the symptoms they disc...
What is the current status of trial NCT07552311?
This trial is currently recruiting. It is a NA study. The enrollment target is 40,000 participants. The study started on 2025-11-21. Estimated completion is 2026-12-31.
What interventions are being tested in trial NCT07552311?
The interventions under investigation include: Fitbit Plan for Care Lab (OTHER), Baseline Model (OTHER).
Who is sponsoring clinical trial NCT07552311?
This trial is sponsored by Fitbit, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07552311's enrollment target sits among peer trials
40,000 7th of 2000 higher than 1,994 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01255748 · 40,000 participants
Registry Study for Radiation Therapy Outcomes
- NCT04994756 · 40,000 participants
Stroke Thrombectomy and Aneurysm Registry
- NCT06768814 · 40,000 participants · NA
Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data
- NCT07109427 · 40,000 participants · NA
Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI